Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL
1 clinical trials · Condition
◉ Watch Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL
| Record | Firm | Date |
|---|---|---|
| Dose Optimization Trial of CD19 Redirected Autologous T Cells (NCT01747486) | University of Pennsylvania | 2013-01-02 |
Track Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL automatically
Every clearance here is in the API, with alerts when new ones post.